Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Greenwich LifeSciences, Inc. (GLSI) had Weighted-Average Shares Outstanding (Diluted) of 13.02M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-15.79M |
|
-- |
|
-- |
|
$16.01M |
|
$-16.01M |
|
$0.22M |
|
$-15.79M |
|
$-15.79M |
|
$-15.79M |
|
$-15.79M |
|
$-15.79M |
|
$-15.79M |
|
$-16.01M |
|
$-16.01M |
|
13.02M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
13.02M |
$-1.21 |
|
$-1.21 |
|
| Balance Sheet Financials | |
$4.09M |
|
-- |
|
$0.00M |
|
$4.09M |
|
$1.56M |
|
-- |
|
-- |
|
$1.56M |
|
$2.53M |
|
$2.53M |
|
$2.53M |
|
13.15M |
|
| Cash Flow Statement Financials | |
$-7.27M |
|
-- |
|
$4.37M |
|
$6.99M |
|
$4.09M |
|
$-2.90M |
|
$7.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-623.07% |
|
-623.51% |
|
-385.68% |
|
-623.07% |
|
$0.19 |
|
$-0.56 |
|
$-0.56 |
|